The UK sun care market continues to grow rapidly as consumers increasingly prioritise SPF and skin protection, new research shows.

The MHRA has approved the UK’s first GLP-1 weight loss tablet, semaglutide (Wegovy), for eligible adults with obesity or overweight and related health conditions. The once-daily oral treatment offers an alternative to injections, with NHS availability subject to NICE approval.

Aesthetic Medicine spoke to experts Dr Veerle Rotsaert and Dr Natasha Berridge to discover the role injectables can play in supporting transgender and gender-diverse patients.

New research found that 17% of UK small business owners take no full days off each year, while founders report working long hours and struggling to switch off from their businesses.